Novonesis stock gains support from DKK 1 billion buyback

Published on 09/22/2026 at 15:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Novonesis stock traded at DKK 430.50 on September 21, 2026, up 0.49 percent. The DKK 1 billion buyback adds support while analyst targets remain above the price.

Industrieanlage mit Fermentationstanks eines daenischen Biotech-Unternehmens — Fotorealistische Ansicht einer Biotech-Anlage von Novonesis (Novozymes), ISIN DK0060336014, mit modernen Fermentationstanks in Bagsvaerd, Illustration mit AI erstellt.

Novonesis stock closed at DKK 430.50 on Nasdaq Copenhagen on September 21, 2026, gaining 0.49 percent on the session. The move came as the company proceeded with a DKK 1 billion share buyback program, giving the market a concrete capital-allocation signal.

Buyback provides support

As Ad Hoc News reported on September 21, 2026, the buyback is valued at EUR 1 billion. At the September 21 closing price, Novonesis stood in the upper half of a 52-week range running from the mid-DKK 300s to the mid-DKK 400s, according to the same dated market coverage.

The combination matters because repurchases can reduce the number of shares outstanding while returning capital to shareholders. For Novonesis, the market is therefore weighing the immediate buyback support against the valuation already reflected in a price above DKK 400.

Analyst targets stay higher

Analyst commentary compiled in a September 20, 2026 overview placed the average Novonesis target above the prevailing price in Danish kroner, with margin expansion and the buyback identified as valuation supports by the covered brokerages.Ad Hoc News

The numerical comparison is straightforward: DKK 430.50 on September 21, 2026, versus an average target above that level. That gap makes expectations for earnings growth and operating margins more important than the buyback alone, because a higher share count reduction does not replace fundamental profit growth.

Stock remains above DKK 400

Novonesis stock ended September 21, 2026, at DKK 430.50 on its primary Nasdaq Copenhagen listing, with the daily change at 0.49 percent. The price level and the stated 52-week band put the shares closer to the annual high than to the historical low within that range.